Founded in 2015, Vitae Industries is a pharmaceutical manufacturing company founded by Daniel DiCiccio ’15. The company utilizes 3D printing technology to streamline and personalize drug manufacturing. Rather than a generic prescription drug, the company’s AutoCompounder allows patients to receive personalized dosages. Since its launch, the company has secured more than $2 million in venture funding.

The venture was a 2015 B-Lab alum and awarded the Manufacturing Awards Emerging Manufacturer by Polaris MEP in 2021.